VOLUME ONE PROGRAM SCHEDULE FACULTY BIOS

Size: px

Start display at page:

Download "VOLUME ONE PROGRAM SCHEDULE FACULTY BIOS"

Horatio Blankenship
5 years ago
Views:

1 Prepared for distribution at the TRIAL BY JURY 2013 Program November 20, 2013 CONTENTS: VOLUME ONE PROGRAM SCHEDULE FACULTY BIOS ENSURING AN IMPARTIAL JURY IN THE AGE OF SOCIAL MEDIA Hon. Amy J. St. Eve United States District Court for the Northern District of Illinois Michael A. Zuckerman Jones Day 2. EFFECTIVE DEFENSE VOIR DIRE: MAKING SENSE OF JURORS EXPERIENCES Cynthia R. Cohen, Ph.D. Verdict Success 3. LET S TALK: ADDRESSING THE CHALLENGES OF INTERNET-ERA JURORS Julie Blackman, Ph.D. Ellen Brickman, Ph.D. DOAR Litigation Consulting 4. SCIENTIFIC JURY SELECTION: HISTORY, PRACTICE, AND CONTROVERSY Audrey Cleary Villanova University 5. JURY QUESTIONNAIRE, UNITED STATES DISTRICT COURT, SOUTHERN DISTRICT OF NEW YORK

2 6. FRIEND OR FOE? SOCIAL MEDIA, THE JURY, AND YOU Leslie Ellis, Ph.D. TrialGraphix 7. JURY SELECTION MODEL VOIR DIRE QUESTIONS PROMULGATED BY DIRECTIVE #21-06 REVISED PROCEDURES AND QUESTIONS New Jersey Superior Court, Appellate Division 8. IN RE: VISA CHECK/MASTERMONEY ANTITRUST LITIGATION, JURY QUESTIONNAIRE HUNTSMAN CORPORATION v. CREDIT SUISSE SECURITIES (USA), L.L.C., ET AL., JURY QUESTIONNAIRE NOVARTIS PHARMACEUTICALS CORPORATION, INTERNATIONAL PHARMACEUTICAL LTD. v. TEVA PHARMACEUTICALS USA, INC., THE PARTIES PROPOSED VOIR DIRE PERSUASION IN OPENING STATEMENT, GENERATING INTEREST IN A CONVINCING MANNER James A. Johnson James A. Johnson, Esq. 12. SUCCEEDING IN THE OPENING STATEMENT Kenneth J. Melilli Creighton University School of Law 1-6

3 13. STORYTELLING IN LEGAL ARGUMENTS Robert D. Minick Keith C. Pounds TrialGraphix/Kroll Ontrack 14. LIBERTY MEDIA CORP. ET AL. v. VIVENDI UNIVERSAL S.A., ET AL., OPENING STATEMENT BY R. STAN MORTENSON R. Stan Mortenson Baker Botts LLP 15. LIBERTY MEDIA CORP. ET AL. v. VIVENDI UNIVERSAL S.A., ET AL., OPENING STATEMENT BY JIM QUINN Jim Quinn Weil, Gotshal & Manges LLP 16. NOVARTIS PHARMACEUTICALS CORPORATION, INTERNATIONAL PHARMACEUTICAL LTD. v. TEVA PHARMACEUTICALS USA, INC., OPENING STATEMENT BY EVAN R. CHESLER Evan R. Chesler 17. DIRECT EXAMINATION: MAKING THE FACTS UNDERSTANDABLE Frank C. Jones Chilton Davis Varner King & Spalding 18. AN IN-DEPTH LOOK AT DIRECT EXAMINATION OF EXPERT WITNESSES Deborah D. Kuchler Kuchler Polk Schell Weiner & Richeson, LLC 19. DIRECT EXAMINATION, A FORGOTTEN ART Jon R. Muth Miller Johnson 20. APPLE INC. v. SAMSUNG ELECTRONICS CO., LTD., ET AL., DIRECT EXAMINATION Joseph J. Mueller Wilmer, Cutler, Pickering, Hale and Dorr LLP 1-7

4 21. APPLE INC. v. SAMSUNG ELECTRONICS CO., LTD., ET AL., DIRECT EXAMINATION Harold J. McElhinny Morrison & Foerster LLP 22. NOVARTIS PHARMACEUTICALS CORPORATION, INTERNATIONAL PHARMACEUTICAL LTD. v. TEVA PHARMACEUTICALS USA, INC., DIRECT EXAMINATION ETHICAL PITFALLS IN JURY TRIALS Michael A. Jacobs Javier Serrano Morrison & Foerster LLP 24. ARMCHAIR JURY CONSULTANTS: THE LEGAL IMPLICATIONS AND BENEFITS OF ONLINE RESEARCH OF PROSPECTIVE JURORS IN THE FACEBOOK ERA Adam J. Hoskins University of Minnesota Law School 25. INTERNET INVESTIGATIONS OF JURORS: ETHICAL AND STRATEGIC CONSIDERATIONS Nancy E. Delaney Jeffrey C. Berman Louisa A. Fennell Curtis, Mallet-Prevost, Colt & Mosle 26. CROSS-EXAMINATION AT TRIAL: STRATEGIES FOR THE DEPOSITION Professor Gary S. Gildin The Dickinson School of Law of the Pennsylvania State University Program Attorney: Laurie Gilbertson 1-8

5 Prepared for distribution at the TRIAL BY JURY 2013 Program November 20, 2013 CONTENTS: VOLUME TWO PROGRAM SCHEDULE PENNSYLVANIA LEGAL AID NETWORK CROSS-EXAMINATION OF A LAY WITNESS Professor Gary S. Gildin The Dickinson School of Law of the Pennsylvania State University 28. TRIAL STRATEGY, PRIOR STATEMENTS Dan K. Webb J. David Reich Winston & Strawn 29. NOVARTIS PHARMACEUTICALS CORPORATION, INTERNATIONAL PHARMACEUTICAL LTD. v. TEVA PHARMACEUTICALS USA, INC., CROSS-EXAMINATION BY DAVID R. MARRIOTT IN RE: VIVENDI UNIVERSAL, S.A. SECURITIES LITIGATION, CROSS-EXAMINATION BY DANIEL SLIFKIN Daniel Slifkin 31. APPLE INC. v. SAMSUNG ELECTRONICS CO., LTD., ET AL., CROSS-EXAMINATION BY WILLIAM F. LEE William F. Lee Wilmer Cutler Pickering Hale and Dorr LLP 2-5

6 32. CLOSING ARGUMENT: THROUGH THE EYES OF A TRIAL ADVOCATE Kevin C. Kennedy The Kennedy Law Firm 33. CLOSING ARGUMENT FROM THE DEFENSE PERSPECTIVE Edgar M. Elliott, IV Christian & Small LLP 34. CRAFTING A SUCCESSFUL CLOSING ARGUMENT C. Barry Montgomery Bradley C. Nahrstadt Williams, Montgomery & John, Ltd. 35. IN RE: VIVENDI UNIVERSAL, S.A. SECURITIES LITIGATION, VIVENDI S CLOSING ARGUMENT WITH DEMONSTRATIVES Paul C. Saunders 36. NOVARTIS PHARMACEUTICALS CORPORATION, INTERNATIONAL PHARMACEUTICAL LTD. v. TEVA PHARMACEUTICALS USA, INC., PLAINTIFF S CLOSING ARGUMENT BY EVAN R. CHESLER Evan R. Chesler INDEX Program Attorney: Laurie Gilbertson 2-6

HON. FRANK J. BAILEY

HON. FRANK J. BAILEY Frank J. Bailey was appointed on January 30, 2009 and served as Chief Judge from December 2010 until December 2014. His chambers are in Boston and he is assigned to the eastern Division.